+ Filter
Loading...
Custom Services order now ship next day

Anti-GLP-1 Recombinant Antibody Products

Anti-GLP-1 Recombinant Antibody Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs offers a wide selection of fully verified anti-GLP-1 recombinant antibodies, each precisely tailored to satisfy the demands of researchers. Our premium selection has undergone rigorous validation to ensure great performance in a variety of applications, including WB, IHC, IF, FC, ELISA, etc. Using our superior recombinant antibody technology, we provide researchers with trustworthy resources to help them with their research in cell biology, disease modeling, and drug discovery.

GLP-1: An Effective Target for Metabolic Disorders

Glucagon-like peptide-1 (GLP-1) has emerged as a significant therapeutic target for metabolic disorders, notably type 2 diabetes and obesity. This incretin hormone regulates glucose levels by increasing insulin production from pancreatic beta cells while decreasing glucagon release. Additionally, GLP-1 induces satiety and slows gastric emptying, contributing to weight management. By mimicking the actions of endogenous GLP-1, GLP-1 receptor agonists have revolutionized the treatment of these conditions, offering substantial benefits in glycemic control, weight loss, and cardiovascular health.

Alternative Names

Glucagon-like peptide-1; GLP-1.

Background

Glucagon-like peptide-1 (GLP-1) is an incretin derived from the transcription product of the proglucagon gene. The major source of GLP-1 in the body is the intestinal L cell that secretes GLP-1 as a gut hormone. The biologically active forms of GLP-1 are: GLP-1-(7-37) and GLP-1-(7-36) NH2. Those peptides result from selective cleavage of the proglucagon molecule.

Anti-GLP-1 rAb Products

Creative Biolabs presents a wide range of recombinant anti-GLP-1 antibodies, meticulously engineered to ensure exceptional specificity and binding affinity. These antibodies cater to various research needs, from fundamental studies to therapeutic advancements, and are available in multiple formats. Our cutting-edge platform empowers us to deliver high-quality resources that enhance our insights into cellular and molecular biology, focusing on pivotal areas such as immunology and cancer research.

Table 1. Featured anti-GLP-1 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
MHH-399 Recombinant Human Anti-GLP-1 Antibody Human Human IgG WB, ELISA, IHC, FS
MOB-399 Recombinant Anti-GLP-1 Antibody Mouse Mouse WB, Dot, FuncS
Gly-043LC Recombinant Anti-Human GLP-1 Antibody (Fc glycosylation) Human Human ELISA

Creative Quality Control

Creative Biolabs offers a varied range of proven recombinant antibodies targeting GLP-1. Our antibodies are precisely developed to provide exceptional specificity, stability, and efficacy. We guarantee that every antibody satisfies the most exacting industry standards by using extensive quality control procedures. These premium antibodies are critical aids to researchers studying the role of GLP-1 in metabolic disorders and other related diseases.

Customer Reviews

Excellent
Fi***p
Recombinant Anti-GLP-1 Antibody (MOB-399)
Creative Biolabs' anti-GLP-1 recombinant antibody has transformed our research capabilities. With its outstanding specificity and sensitivity, we have been able to obtain accurate and dependable results in our studies on GLP-1 receptor signaling. This antibody's exceptional performance across diverse applications such as Western blotting and immunohistochemistry has greatly expedited our research efforts.
6/Dec/2023
Excellent
An***s
Recombinant Human Anti-GLP-1 Antibody (CAT#: MHH-399)
We have consistently been satisfied with the outstanding quality and effectiveness of Creative Biolabs' anti-GLP-1 recombinant antibody. Its remarkable affinity and reliable lot-to-lot reproducibility have proven essential for our research needs. Additionally, the technical support from Creative Biolabs has been exemplary, enabling us to achieve the best results in our experiments with this antibody.
12/Feb/2024

rAb Production

Creative Biolabs leverages cutting-edge genetic engineering methodologies to develop high-quality anti-GLP-1 antibodies, ensuring reliable availability for diverse research purposes.

Featured Anti-GLP-1 Recombinant Antibody Production PlatformsFig.1 Milligram-scale. (Creative Biolabs Original)
Fig.1 Milligram-scale anti-GLP-1 recombinant antibody production.

Fig.2 Gram-scale. (Creative Biolabs Original)Fig.2 Gram-scale anti-GLP-1 recombinant antibody production.

rAb Modalities

Creative Biolabs provides a diverse selection of high-quality anti-GLP-1 recombinant antibodies tailored to meet global research demands.

Fig.3 GLP-1 antibody production and modalities. (Creative Biolabs Original)Fig.3 Full-length anti-GLP-1 recombinant antibody production and modalities.

GLP-1-Targeted Drug Information

Table 2. Public drug targeting GLP-1.

Highest Phase Mechanism of Action Product Category Condition Organization
Bostal Drug Delivery
iX Biopharma
Lexaria Bioscience
MSD KK
Novo Nordisk (Originator)
Launched - 2018 Glucagon-Like Peptide 1 (GLP-1) Analogues
Polypeptides, from 10 AA to 40 AA
Recombinant proteins
Alcoholic liver disease
Cardiovascular Disorders
Chronic kidney disease
Dementia, Alzheimer's type
Diabetes
Diabetes type 2
Non-alcoholic steatohepatitis (NASH)
Obesity
Parkinson's disease
Peripheral arterial disease (PAD)
Retinopathy, diabetic
Cipla
Lilly (Originator)
Lupin
Sumitomo Dainippon Pharma (Sumitomo Pharma)
Sumitomo Pharma
Launched - 2014 Fc Fusion Proteins
Glucagon-Like Peptide 1 (GLP-1) Analogues
Polypeptides, from 41 AA
Cardiovascular Disorders
Diabetes
Diabetes type 2
GlaxoSmithKline (GSK)
GSK (Originator)
Human Genome Sciences (GSK)
Launched - 2014 Fusion Proteins
Glucagon-Like Peptide 1 (GLP-1) Analogues
Polypeptides, from 41 AA
Diabetes type 1
Diabetes type 2
Heart failure
4P-Pharma
Cincinnati Children's Hospital Med Cent
Imperial College
Lancaster University
Nanexa
Novo Nordisk (Originator)
Launched - 2009 Glucagon-Like Peptide 1 (GLP-1) Analogues
Polypeptides, from 10 AA to 40 AA
Recombinant proteins
Amyotrophic lateral sclerosis
Arthritis, psoriatic
Cardiovascular Disorders
Dementia, Alzheimer's type
Diabetes type 1
Diabetes type 2
Diabetic nephropathy
Diabetic neuropathy
Maturity onset diabetes of the young (MODY)
Non-alcoholic steatohepatitis (NASH)
Obesity
Osteoarthritis, knee
Parkinson's disease
Sleep apnea
Gmax Biopharm (Originator) Phase III Fusion Proteins
Humanized Monoclonal Antibodies
Polypeptides, from 41 AA
Diabetes type 2
Obesity
Hanmi (Originator)
Sanofi
Phase III Fc Fusion Proteins
Glucagon-Like Peptide 1 (GLP-1) Analogues
Polypeptides, from 41 AA
Diabetes
Diabetes type 2
Obesity
Shanghai Yinnuo Pharmaceutical Technology
University of Toronto (Originator)
Phase II/III Fc Fusion Proteins
Glucagon-Like Peptide 1 (GLP-1) Analogues
Polypeptides, from 41 AA
Diabetes
Diabetes type 2
Amgen (Originator) Phase II Fusion Proteins
Glucagon-Like Peptide 1 (GLP-1) Analogues
Human Monoclonal Antibodies
Immunoconjugates
Polypeptides, from 41 AA
Diabetes type 2
Obesity
China Shijiazhuang Pharmaceutical (CSPC) (CSPC Pharmaceutical Group)
CSPC Pharmaceutical Group
I-Mab Biopharma (Originator)
Phase II Fc Fusion Proteins
Glucagon-Like Peptide 1 (GLP-1) Analogues
Polypeptides, from 41 AA
Dementia, Alzheimer's type
Diabetes type 2
Non-alcoholic steatohepatitis (NASH)
Obesity
Hanmi (Originator) Phase II Fc Fusion Proteins
Polypeptides, from 41 AA
Idiopathic pulmonary fibrosis
Non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic steatohepatitis (NASH)
Obesity
Parkinson's disease
Primary biliary cholangitis
Sclerosing cholangitis

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

To learn more about our high-quality anti-GLP-1 recombinant antibody products, including their specific applications, target species, and detailed product specifications, please feel free to contact us. Our experienced team is glad to help you identify the best antibody solution for your research needs.

  • 0
  • 0
Cart
    Go to compare

    Go to compare